Table 5 Haloperidol versus placebo – 1 trial, 40 participants [15]
Main outcomes | Hal'dol | Placebo | RR (95% CI) |
|---|---|---|---|
Not improved by 2 hours | 2/29 | 4/11 | 0.19 (0.04–0.9) |
Needing another injection | Majority in both groups | ||
Mental state: asleep – by 2 hours | 1/29 | 0/11 | - |
Leaving the study early | 0/29 | 0/11 | - |
Adverse effects: needing antiparkinsonian medication | 6/29 | 0/11 | - |